Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma ß-amyloid and cognitive decline.

Archives of neurology - 1 Dec 2010

Cosentino Stephanie A, Stern Yaakov, Sokolov Elisaveta, Scarmeas Nikolaos, Manly Jennifer J, Tang Ming Xin, Schupf Nicole, Mayeux Richard P

Abstract excerpt

OBJECTIVES: To determine if plasma β-amyloid (Aβ) levels (1) can be linked to specific cognitive changes that constitute conversion to Alzheimer disease (AD) and (2) correspond to cognitive change independent of dementia. DESIGN: Longitudinal study including 3 visits during approximately 4¹/₂ years (2000-2006). SETTING: Northern Manhattan community. PARTICIPANTS: Eight hundred eighty individuals from a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Cognition Disorders

Share to Enzyme-Linked Immunosorbent Assay

Share to Longitudinal Studies

Share to Peptide Fragments

Source

Open in PubMed Open full text

Identifiers

PMID: 20697031
DOI: 10.1001/archneurol.2010.189
PMCID: PMC3006003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma ß-amyloid and cognitive decline.PMID 20697031Read ↗

Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based studySemantic proximity Read ↗

Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Semantic proximity Read ↗

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Semantic proximity Read ↗

Predicting Progression & Cognitive Decline in Amyloid-Positive Patients with Alzheimer's DiseaseSemantic proximity Read ↗

Plasma biomarkers predict amyloid conversion and cognitive decline in cognitively unimpaired adultsSemantic proximity Read ↗

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.Semantic proximity Read ↗

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.Semantic proximity Read ↗

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.Semantic proximity Read ↗

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.Semantic proximity Read ↗

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal studySemantic proximity Read ↗

The Relationship between Alcohol Use Disorder, Measures of Cognitive Decline, and Alzheimer Disease Biomarkers in Older AdultsSemantic proximity Read ↗

Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.